Prospective Assessment of Impact of Personalized Dosing of Low-dose Human Chorionic Gonadotropin (hCG) on in Vitro Fertilization (IVF) Outcomes

NCT04852029 · clinicaltrials.gov ↗
NA
Phase
TERMINATED
Status
12
Enrollment
OTHER
Sponsor class

Stopped recruitment issues

Conditions

Interventions

Sponsor

Reproductive Medicine Associates of New Jersey